Tag: CRTD

Hot Pick Review & More

NASDAQ Stock Runners: 

We had a couple of stock-only plays on the NASDAQ in Friday’s premarket report, in PHUN and CRTD, which both put up some very impressive intraday runs for big board plays.

We always encourage to add our daily extended watchlist tags to your own watchlists on a given day, as we very routinely unearth solid runners such as these.

Phunware, Inc. PHUN 
Initial Alert: Oct 22nd
Range: 5.5185-24.04
Gained: +336%
_____

Creatd, Inc. CRTD
Initial Alert: Oct 22nd
Range: 4.92-9.80
Gained: +99%

Winning Options Calls: 

As is typical for us, we also formulated some fresh options ideas for Friday’s report as well. We took a chance on two different plays, and were met with intraday success on both counts, closing the week out with strength.

Out targets were the STX Weekly $82.50-85 Calls, and the AXP Weekly $177.50-182.50 Calls, In both cases, we had a chance to snare daily profits of a significant nature, with all but one single target breaking into multibag territory on the day.

STX Weekly $82.50-85 Calls
$82.50: 2.80-5.10 (+82%)
$85: .89-2.98 (+234%)
_____

AXP Weekly $177.50-182.50 Calls
$177.50: 5.30-11.30 (+113%)
$180: 3.00-8.85 (+195%)
$182.50: 1.10-6.45 (+486%)

Fresh Options Ideas:
OTIS Weekly $85 Calls 

Extended Watchlist:
MARK, BENE, SONM, COMS, INPX, CETX, GBHL, CBMJ, DRNG, ICOA, PHIL

Multiple Key Updates & Big Runners

Medigus, Ltd. MDGS – News Alert:

We’ve got more fresh news hitting the wires this morning from MDGS. One of the things we like best about the company is the frequency with which it communicates with its shareholders.

Today’s release pertains to the hiring of an advisory firm to guide Polyrizon, in which Medigus is a stakeholder, toward FDA approval for its nasal gels which are preventative against viruses, including COVID-19 and the flu.

Tel Aviv, Israel, Oct. 22, 2021 (GLOBE NEWSWIRE) — Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, announced today that Polyrizon Ltd., (37.01%), that it has engaged with a full-service Contract Research Organisation (CRO), to advise the Company in its pursuit of Food and Drug Administration (FDA) submission for its products. (>>View Full PR)

Watchlist Updates: 

We typically encourage our readers to keep track of not only the featured items in our daily reports, but our ‘Extended Watchlists’ as well. They often include hidden opportunities waiting to be unearthed.

Such was the case yesterday with DWAC, which was included in our premarket report before exploding from a daily low of 12.62 up as high as 52.00. That works out to an intraday run of 312%  Our overall observed range has increased already this morning with a premarket high of 93.43, which marks a rise of 640%

We also signaled MGTI on Monday morning, and it has posted a solid intraweek performance thus far. The stock came up from a low of .041  to a high of .064, an increase of 58%

Options Recap: 

Last but not least, we went three for three on options ideas in yesterday’s report, which provided the following intraday gain opportunities for our readers:

CSX Weekly $34-36 Calls
$34: 1.30-1.84 (+42%)
$35: .45-.90 (+100%)
$36: .05-.24 (+380%)
_____

BX Weekly $130-133 Calls
$130: 2.50-4.83 (+93%)
$131: 1.69-3.67 (+117%)
$132: .93-3.05 (+228%)
$133: .72-2.32 (+222%)
_____

T Weekly $25.50-26.50 Calls 
$25.50: .20-.34 (+70%)
$26: .15-.36 (+140%)
$26.50: .05-.11 (+120%)
_____

Fresh Options Ideas: 
STX Weekly $82.50-85 Calls
AXP Weekly $177.50-182.50 Calls

Extended Watchlist:
PHUN, CRTD, GROM, DATS, CZNI, SEGI, TONR, ASTI, NSAV, CIVX, CAGC

Options Recap, Post-Earnings Ideas & More

More Options Review:  

We’ve got options updates on deck for this morning, and there is actually a fairly decent slate of earnings reporters on the docket today, so we’ll take a look into some of those as well.

As for recaps on options calls we’ve made recently, two of the targets that we reviewed yesterday morning continued their momentum and set new highs for us during the session. They were Friday’s alert on the GBX 07/16 $40 Calls and Tuesday’s alert on the ARWR 07/16 $65 Calls. Additionally, we witnessed new highs in the DRI 07/16 $140-145 Calls, which we initially targeted a few weeks back on June 24th.

These are the updated figures on those plays, all of which expire at the end of the week:

GBX 07/16 $40 Calls
$40: 1.40-5.40 (+286%)
_____

ARWR 07/16 $65 Calls
$65: 1.28-4.00 (+213%)
_____

DRI 07/16 $140-145 Calls
$140: 2.71-10.10 (+273%)
145: 1.10-5.45 (+395%)

Post-Earnings Options Ideas: 

As we’ve been mentioning, next week is when the floodgates for earnings reporters really swing wide open, but for the time being, we have a couple that dropped their quarterlies this morning in which we will select some targets.

GS Weekly $380-385 Calls
PEP Weekly $149-152.50 Calls 

Extended Watchlist:
OSAT, CRTD, WORX, BAOS, DPW, BLIN, NOK, ADGO, SFLM, GVSI, FERN, SFLM